Edwards Lifesciences Company Insiders

Edwards Lifesciences' latest congressional trading

Edwards Lifesciences Management Team Effectiveness

The company has Return on Asset (ROA) of 0.1065 % which means that for every $100 of assets, it generated a profit of $0.1065. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.171 %, which means that it produced $0.171 on every 100 dollars invested by current stockholders. Edwards Lifesciences' management efficiency ratios could be used to measure how well Edwards Lifesciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.1 in 2025. Return On Capital Employed is likely to drop to 0.14 in 2025. At this time, Edwards Lifesciences' Fixed Asset Turnover is fairly stable compared to the past year. Asset Turnover is likely to climb to 0.80 in 2025, whereas Return On Tangible Assets are likely to drop 0.1 in 2025. Common Stock Shares Outstanding is likely to climb to about 550.8 M in 2025. Net Income Applicable To Common Shares is likely to climb to about 1.8 B in 2025

Edwards Lifesciences Workforce Comparison

Edwards Lifesciences Profit Margins

The company has Net Profit Margin (PM) of 0.77 %, which suggests that even a small decline in it sales will erase profits and may result in a net loss, or a negative profit margin. This is way below average. Likewise, it shows Net Operating Margin (NOM) of 0.24 %, which signifies that for every $100 of sales, it has a net operating income of $0.24.

Edwards Lifesciences Insider Trading History

Edwards Lifesciences Notable Stakeholders

The success or failure of an entity such as Edwards Lifesciences Corp often depends on how effective the management is. Edwards Lifesciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Edwards management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Edwards management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Edwards Lifesciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Edwards Lifesciences Corp. Check Edwards Lifesciences' Beneish M Score to see the likelihood of Edwards Lifesciences' management manipulating its earnings.

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.